title: BCR-ABL positive chronic myeloid leukemia with concurrent JAK2(V617F) positive myelodysplastic syndrome/myeloproliferative neoplasm (RARS-T).
authors.affiliation: Institute of Pathology, University of Würzburg, Josef-Schneiderstr.2, Würzburg D-97080, Germany. stefan.gattenloehner@mail.uni-wuerzburg.de
authors.forename: Stefan
authors.initials: S
authors.lastname: Gattenlohner
authors.forename: Hans-Ulrich
authors.initials: HU
authors.lastname: Völker
authors.forename: Benjamin
authors.initials: B
authors.lastname: Etschmann
authors.forename: Hermann
authors.initials: H
authors.lastname: Einsele
authors.forename: Hans-Konrad
authors.initials: HK
authors.lastname: Müller-Hermelink
mesh_terms: D000368:Aged; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D053614:Janus Kinase 2 / Q000235:genetics; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications*; D008297:Male; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000201:enzymology / Q000209:etiology* / Q000235:genetics; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D053614:Janus Kinase 2